A phase-I trial of DSP-0038 in Alzheimer's disease associated psychosis
Latest Information Update: 17 May 2021
At a glance
- Drugs DSP 0038 (Primary)
- Indications Psychotic disorders
- Focus Adverse reactions
- Sponsors Sumitomo Pharma
- 17 May 2021 New trial record